PH20 polypeptide variants, formulations and uses thereof
US12264345B1 · kind B1 · utility
0Cited by
91References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2024 |
| Grant date | Apr 1, 2025 |
| Priority date | — |
| Expiry date | Jul 19, 2044 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.